Literature DB >> 21058925

Chronic baclofen abuse and withdrawal delirium.

Julian J Nasti, Vlasios Brakoulias.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21058925     DOI： 10.3109/00048674.2010.524622

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN： 0004-8674            Impact factor:   5.744


× No keyword cloud information.
  5 in total

1.  Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2012-06-13       Impact factor: 4.492

Review 2.  GABAB Receptors and Alcohol Use Disorders: Clinical Studies.

Authors:  Warren B Logge; Kirsten C Morley; Paul S Haber
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.

Authors:  A Hilliard; C Stott; S Wright; G Guy; G Pryce; S Al-Izki; C Bolton; G Giovannoni
Journal:  ISRN Neurol       Date:  2012-08-07

Review 4.  GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence.

Authors:  Roberta Agabio; Giancarlo Colombo
Journal:  Front Neurosci       Date:  2014-06-06       Impact factor: 4.677

5.  Abuse Liability of Baclofen.

Authors:  Samir Kumar Praharaj
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-02-28       Impact factor: 2.582
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.